chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two weeks after these 3 vaccines given on same arm, patient started feeling electrical wave type of pain radiating into shoulder and elbow joint. A few weeks after that, pain progressed to the point that patient couldn't move her arm to do daily activities. She took some Ibuprofen which tend to help somewhat. She discussed it with her doctor on 01.30.18, and doctor recommended to do some exercise. Pain still didn't go away. On 04.05.18, doctor ordered X-ray of the arm and shoulder. On 05.31.18, patient brought it to pharmacy's attention the first time.
States heard an unusual noise (whoosh) at time of immunization. Later same day arm very painful "I couldn't even lift it" this occurred "on  and off" for four days. Since immunization, sporadic pain on and off.
Vasovagal response at home, followed by going to ER - high blood pressure, lightheadedness. There for 3.5 hours. B/P 173/92 on discharge. CScan, ECG 12 lead, and troponin, mg, phosphorus, hemogram, plus, diff, basic metabolic panel.
Pt called pharmacy 2 days later complaining of swollen, warm to touch, painful arm at the injection site.  Pt went to doctor's office to get it checked out.
Pt reported lightheadedness after injection. Pt given water, but symptoms persisted. Taken to med obs at 9:34. All vital signs stable. Water administered. Pt reported resolution of symptoms. Recheck VSS. Pt released at 9:47
Rash like symptom with vaccination; Received the Moderna COVID-19 Vaccine and experienced a side effect.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash like symptom with vaccination) and VACCINATION COMPLICATION (Received the Moderna COVID-19 Vaccine and experienced a side effect.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash like symptom with vaccination) and VACCINATION COMPLICATION (Received the Moderna COVID-19 Vaccine and experienced a side effect.). At the time of the report, RASH (Rash like symptom with vaccination) and VACCINATION COMPLICATION (Received the Moderna COVID-19 Vaccine and experienced a side effect.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Additional document was received on 28 June 2021 which contain added event :received the Moderna COVID-19 Vaccine and experienced a side effect.
pt recv vax & became very pale & felt shaky;pt did not eat breakfast; BP 116/82;pt in bed w/head lower than legs;crackers & juice taken;BP 112/80;pt was able to stand w/out feeling dizzy;later reported cold sweats, rapid heart beat, pale, t
Muscle aches occurred during the day. Around 12 hours after the vaccine- headaches, chills and severe shaking,  The symptoms  resolved in about an hour or so .  I took 2 Tylenol after i could get out of bed safely.  Finally  went back to sleep.
I started having panic attacks in late March of 2022. I've gone to the doctor several times for it. My blood pressure gets really high during these attacks. There's nothing that I can think of that brings them on. They just happen out of nowhere. I was prescribed XANAX, alprazolam, fluvoxamine maleate, and fluoxetine HCL. The attacks don't happen everyday. They happen once or twice a week, and I can't control them.
8PM-cough, throat tight, "lump" in throat, throat red/streaked. Used cough drop. 8:23PM Benadryl 25mg. ~9PM throat "opens up", fell asleep. 10PM chills, shaking, teeth chatter, muscle spasms in arms, legs, & neck. No fever. 10:40PM Tylenol 500mg. 10:40PM "hear pulse", "achy", awake every 1-2 hours all night. 11PM decrease in spasms, fell asleep. 11/30 8AM awaken exhausted, shower. 8:30-9AM vomit (fluid) X4. 9-11AM sleep. 11AM decrease Nausea. 11/30 &12/1 able to be up but extremely tired. 12/2 "back to normal". Mild soreness/redness at injection site (no streaks or rash). No Headache. No Fever. No Issues since. First time receiving High-Dose. No Issues with any other flu shot in the past. Patient did notify physician.
3 days of high pitched unusual crying, inconsolable p/vax on 11JAN94, 12JAN94, 13JAN94; full recovery;
This spontaneous report has received from a nurse referring to a male patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date, the patient was administered M-M-R II (strength, dose, rout, frequency, lot# and expiration date were not provided) for prophylaxis. At the same time, the patient moved while being administered his M-M-R II, booster shot and the needle came out of the patient's arm because he moved, and "only 75%" of the dose was administered. The patient's parents didn't want to have the patient receive another injection to administer the rest of the dose (Incomplete dose administered).
Information has been received from a physician concerning a 25 year old female patient with asplenia who in September 2008, was vaccinated with the second 0.5 ml dose of PNEUMOVAX 23. In September 2008, the patient experienced fever, swelling in the arm in which she received the vaccination, generalized aches and pains throughout her body. The patient presented to the emergency room and she was found to have a white blood cell count of 25000 and an increased sedimentation rate. Then the patient was admitted to the hospital in order to determine the cause of elevated white blood cell count and remained in the hospital for 6 days. Blood cultures and CBC were performed (no results provided). Fever, swelling in the arm in which she received the vaccination, generalized aches and pains throughout her body, white blood cell count of 25000 and increased sedimentation rate were considered to be disabling. Additional information has been requested.
Fever, body aches, chills, difficulty breathing (had to use inhaler three times). Spasms, severe abdominal pain and pain in lungs after inhaler use. Deliriousness from fever. Nausea, dry heaving but no vomiting. The symptoms started around 4:00pm, about two hours after receiving the vaccine. The worst of it lasted for about 14 hours, until around 6:00am the next morning, when I took painkillers to be able to sleep.
Sore arm for first few days, about 10 days after vaccine I noticed ringing in ears that keeps getting worse. Also at the same time I developed what I believe is a histamine over-reaction  with worsening rashes and migraines almost daily.
Hernia surgery; Blood pressure was running 150/90; This spontaneous case was reported by a consumer and describes the occurrence of HERNIA REPAIR (Hernia surgery) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included RELUGOLIX (ORGOVYX) and ENZALUTAMIDE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERNIA REPAIR (Hernia surgery) (seriousness criterion hospitalization) and HYPERTENSION (Blood pressure was running 150/90). The patient was treated with IBUPROFEN for Hernia, at a dose of 600 mg. At the time of the report, HERNIA REPAIR (Hernia surgery) and HYPERTENSION (Blood pressure was running 150/90) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 150/90 (High) Blood pressure was running 150/90.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Company comment: This Spontaneous case concerns a 67-year-old, male patient, with no reported medical history, who experienced the unexpected, serious(hospitalization) event of hernia repair. The event occurred after receiving an unknown dose number of mRNA-1273 vaccine on an unknown date. Rechallenge was not applicable, as vaccination date, dose number and events dates are not available. The benefit -risk relationship of mRNA -1273 Vaccine is not affected by this report. Seriousness criteria of hospitalization was captured for the event according to SD, however; there was no information provided on hospitalization dates, clinical course and/or discharge summary.   Reporter did not allow further contact; Sender's Comments: This Spontaneous case concerns a 67-year-old, male patient, with no reported medical history, who experienced the unexpected, serious(hospitalization) event of hernia repair. The event occurred after receiving an unknown dose number of mRNA-1273 vaccine on an unknown date. Rechallenge was not applicable, as vaccination date, dose number and events dates are not available. The benefit -risk relationship of mRNA -1273 Vaccine is not affected by this report. Seriousness criteria of hospitalization was captured for the event according to SD, however; there was no information provided on hospitalization dates, clinical course and/or discharge summary.
Blood in stool. Mucous in stool. Increased vomiting since vaccination. Drop on growth curve despite adequate feeds.
G47.33 OBSTRUCTIVE SLEEP APNEA 4/27/2023 PULMONARY HTN G47.33 OBSTRUCTIVE SLEEP APNEA 4/27/2023 PULMONARY HTN
Pruritus with erythema to forehead on 9/13/16. Took BENADRYL 25 MG po x 1 at home. 9/14/16 c/o severe pruritus/increased erythema with edema to forehead. Starting to have lower lip numbness. Took another BENADRYL 25 MG po x 1 on 9/14/16. Referred to worker's comp.
The patient received unspecified dose of either VARIVAX or a PROQUAD dose that was improperly stored; No adverse event; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender.      The patient's concurrent conditions, medical history, drug/allergy reactions, were not reported. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT).   It was reported by the medical assistant that on 04-FEB-2020, the patient was vaccinated with unspecified doses of improperly stored vaccines: either varicella virus vaccine live (Oka/Merck)(VARIVAX) (strength, vaccination scheme, route of administration, and anatomical location, were not reported) (lot # S025610 (verified to be a valid lot number) expiration date reported and established as 18-AUG-2021 for prophylaxis or measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) (strength, vaccination scheme, route of administration, and anatomical location, were not reported) (lot # S017250 (verified to be a valid lot number) expiration date reported and established as 01-DEC-2020 for prophylaxis. The therapy type of the lot number S017250 was rHA. The sterile diluent (MERCK STERILE DILUENT) was properly stored. The temperature excursion occurred at 7.5 Fahrenheit (F) with a time frame of 15 minutes.  There were no previous temperature excursions. The call was given because of a data logger. No symptoms were reported.
Developed significant pain in right shoulder approximately 6 hours after vaccine that lasted about 52 hours.  No redness or swelling  noted but persistent pain in joint on movement.
She got her vaccine, after about a week had a runny nose, eyes were watering, nose was running, terrible cough, throat hurting quite a bit, body started hurting, full over body aches, was completely laid up, so sick.  Had chills, her lymph nodes were swollen.  It has gone now ,but she really suffered for a week or so.  Trying to get back to her old self now and hoping to get her health back after being so ill.  She was feeling off, the first thing she noticed her eyes were blurry, wasn't seeing right was the first symptom.  Then it progressed from there, and became worse and worse.  She had a COVID test and was negative x 4.  She did not have any symptoms prior to the vaccine.   Doctor called her and asked her to do blood work, CBC, general check up but nothing related to the vaccine.   She is still very weak.  She was taking Ibuprofen and Nyquil at night.    She cannot do anything, no energy at all.
I noticed significant swelling bilaterally in my supraclavicular areas that started approximately 18 hours after the vaccine. I have never had any swelling like this before so I completely attribute this to the vaccine. My fellow medical staff coworkers also noticed it too and were concerned. It was itchy like and palpated spongy and felt very uncomfortable. I was also concerned for my airway as it was very close to the neck. It took about 36-48 hours to go away. I contacted my employee health staff. This makes me very concerned for future flu vaccines.
Information has been received from a health professional concerning a patient in seventh grade who was vaccinated with a dose of Varivax. Subsequently the patient experienced chickenpox. Additional information has been requested.
One week after receiving shot, I have a rash at injection site.  Rash is red, raised and itchy, approximately 2-3 inches in diameter.
Sore arm; Warm to touch; Redness; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm), INJECTION SITE WARMTH (Warm to touch), INJECTION SITE ERYTHEMA (Redness) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), INJECTION SITE WARMTH (Warm to touch), INJECTION SITE ERYTHEMA (Redness) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), INJECTION SITE WARMTH (Warm to touch), INJECTION SITE ERYTHEMA (Redness) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (Inconclusive) fever of 100.0.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   This case was linked .   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up information received on 27-APR-2021 contains non-significant information.
Patient presented a COVID card indicating full doses of Moderna received on 3/5/21 and 4/2/21, patient was given a half dose booster on 10/27/21. Upon further investigation, patient had already received a full dose booster shot on 08/21/21.
Chills, low fever, headache about 6 hrs. after second shot. Rapid heartbeat starting about 8 hrs. after second shot. All these symptoms lasted about 16 hours. Also, nausea beginning the morning after the second shot and lasting about 6 hrs. Felt quite fatigued for about 2 days.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. It was reported that on 15-MAR-2013, last Friday, the patient was vaccinated with a dose of ZOSTAVAX (lot number and route not reported). No other co suspect or concomitant medications were reported. The pharmacist reported that the patient developed an injection site reaction following vaccination with ZOSTAVAX (no rash). The pharmacist reported that the injection site reaction was described as a red area (the total red area was 4 to 5 inches in diameter at the injection site, with a darker oval of red at the center that was about 2 inches in diameter), swollen, warm and painful to the touch area at the injection site of the ZOSTAVAX vaccination, without rash or itching. As of 18-MAR-2013, the patient's condition was progressing. This case is linked to the case # 1303USA010770. Additional information has been requested.
Patient reported stomach cramping and had 5 bowel movements after vaccine.  Stated was nervous for the shot.  Took blood pressure 137/80.  No diarrhea bowel movements were normal.  Monitored pt and she felt better and reported still a little cramping but much better.
Pt recvd vax 1st dose of vax on 15MAR92 w/no problem; On 15APR92 recvd 2nd dose of vax & 5 hrs p/vax 6 to 8 hrs p/vax devel erythematous area approx the size of a quarter @ the inject site w/heat & redness; palpate a knot beneath the lesion
Patient received a vaccine that was 10 days beyond its use-by date (3/6/23).  (Mislabeled 4/6/23)  Per physician, patient did not experience any adverse effects.
higher bp than usual 140/100 usually 90/60 head and neck ache L shoulder light wheezing/sh-o-breath,  severe sinus pain L; draining then swollen, dizzy, nauseous, chills starting 10 am, worsening through next 24 hrs
10/4/99 pt had fever, aches, red swollen, weird taste in the mouth;
20 MINUTES AFTER RECEIVING H. ZOSTER VACCINE EXPERIENCED WEAKNESS, LIGHT HEADEDNESS, FATIGUE, DIZZINESS, CONFUSION, UNABLE TO WORK OR DRIVE, 2"X2" AREA OF INDURATION AT SITE.  NO FEVER
chest pain that was sharp; feels an occasional slight chest discomfort; Elevated troponin levels; Blood pressure was ranging around 140/90; achy; fever 102; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain that was sharp) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21-2A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and AZELASTINE for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced MYALGIA (achy), PYREXIA (fever 102) and FATIGUE (felt tired). On 16-Apr-2021, the patient experienced CHEST PAIN (chest pain that was sharp) (seriousness criterion hospitalization), TROPONIN INCREASED (Elevated troponin levels) and BLOOD PRESSURE INCREASED (Blood pressure was ranging around 140/90). On 24-May-2021, the patient experienced CHEST DISCOMFORT (feels an occasional slight chest discomfort). The patient was hospitalized on 16-Apr-2021 due to CHEST PAIN. On 16-Apr-2021, TROPONIN INCREASED (Elevated troponin levels) had resolved. At the time of the report, CHEST PAIN (chest pain that was sharp), MYALGIA (achy), PYREXIA (fever 102) and FATIGUE (felt tired) was resolving and BLOOD PRESSURE INCREASED (Blood pressure was ranging around 140/90) and CHEST DISCOMFORT (feels an occasional slight chest discomfort) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Blood pressure measurement: 140/90 (High) His normal rage is 120/70. On 16-Apr-2021, Catheterisation cardiac: normal (normal) normal. On 16-Apr-2021, Echocardiogram: normal (normal) Normal. On 16-Apr-2021, Electrocardiogram: normal (normal) normal. On 16-Apr-2021, Pulmonary function test: clear (normal) Lung test was clear.. On 16-Apr-2021, Troponin: elevated (High) elevated, elevated (High) was elevated from the first. and normal (normal) the last test done was normal.         No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Swelling in lips, face, and legs, hives all over.  Headache that has been on going 4 days, fever, chills body aches, fatigue and feeling hard to breath some times, and uncontrollable diarrhea that will hit suddenly and out of no where.
Feeling faint. Passed out at home x2. Pain and tenderness in left arm. Feeling weak x4days.
Sore injection site, moderate pain, started immediately, about 48 hr. From about 10 hr from injection time, for about 24 hr- extreme fatigue (stayed in bed all day, could not read), chills, muscle pain, head ache, shivering. Much improved by 48 hr from injection (but not perfect yet).  Same side effects, but not as strong, also occurred on the 1st injection in July.
Fever; Runny nose; sick; This is a spontaneous report from a Pfizer program. A contactable consumer (patients Daughter) reported for her mother. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 04May2021 as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced fever, runny nose and sick. The seriousness of the events was not specified by reporter. Provided  contact number. Unable to warm transfer , the call got disconnected while transferring the call. Created Manual AE form. Medical questions were addressed by this program and forwarded/referred to Medical Information. Reporter asked if she could get the second dose even if she was sick. The clinical outcome of the events was unknown.  Information regarding lot/batch number has been requested.
more than 36 days passed since patient received the first dose of primary series. Second dose has not been administered at the time of call; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (more than 36 days passed since patient received the first dose of primary series. Second dose has not been administered at the time of call) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 27-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (more than 36 days passed since patient received the first dose of primary series. Second dose has not been administered at the time of call) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (more than 36 days passed since patient received the first dose of primary series. Second dose has not been administered at the time of call) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (more than 36 days passed since patient received the first dose of primary series. Second dose has not been administered at the time of call).    No concomitant medication were reported. No treatment information was provided by the reporter.
Registered Nurse gave Flu shot in right upper arm, ever since then right upper arm & shoulder are in pain & hurting; can't sleep on it can't lift it without it hurting also when driving it hurts.